Huixia Qin, Xuhua Xiao, Houxiang Ya, Jinhai Li, Fugang Liang, Haiqing Jin, Lianghuan Liao, Yaohua Li, Jiahui Qin, Jue Yu, Jing Gu, Chunmei Zhou, Ming Jin, Ying Miao, Shuqun Li
Transarterial chemoembolisation (TACE) is a standard therapy for hepatocellular carcinoma (HCC). However, adverse events, including abdominal pain, are common. This study aimed to investigate and verify the feasibility of a nomogram model to predict severe abdominal pain after first conventional TACE (cTACE) among patients with HCC. Patients with HCC treated with cTACE between October 28, 2019, and August 5, 2022, at a single centre were enrolled (n = 216). Patients were divided into training and validation cohorts (ratio, 7:3)...
December 16, 2023: Scientific Reports